Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen.

Saved in:
Bibliographic Details
Title: Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen.
Authors: Laurent C; Institut Universitaire Cancer-Oncopole, CHU Toulouse, INSERM U1037, Toulouse, France., Flores M; LYSARC, Pierre Bénite, France., Chartier L; LYSARC, Pierre Bénite, France., Huet S; Hospices Civils De Lyon, Pierre Bénite, France., Bolen CR; Genentech Inc., South San Francisco, California, USA., Venstrom JM; Genentech Inc., South San Francisco, California, USA., Chassagne-Clément C; Centre Léon Bérard, Lyon, France., Dartigues-Cuilléres P; Institut Gustave Roussy, Villejuif, France., Charlotte F; Centre Hospitalier Pitié-Salpêtriére, Paris, France., Tesson B; LYSARC, Pierre Bénite, France., Salles G; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Morschhauser F; Hôpital Claude Huriez, Lille, France., Xerri L; Institut Paoli-Calmettes, CRCM and Aix-Marseille University, Marseille, France.
Source: British journal of haematology [Br J Haematol] 2023 Aug; Vol. 202 (3), pp. 686-689. Date of Electronic Publication: 2023 May 22.
Publication Type: Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2141
DOI:10.1111/bjh.18881